Moneycontrol Be a Pro
Get App
SENSEX NIFTY
Shasun Pharmaceuticals Chairman's Speech > Engineering - Heavy > Chairman's Speech from Shasun Pharmaceuticals - BSE: 524552, NSE: SHASUNPHAR
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > CHAIRMANS SPEECH - Shasun Pharmaceuticals

Shasun Pharmaceuticals

BSE: 524552|NSE: SHASUNPHAR|ISIN: INE317A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Shasun Pharmaceuticals is not traded in the last 30 days
Shasun Pharmaceuticals is not traded in the last 30 days
Mar 06
Chairman's Speech (Shasun Pharmaceuticals) Year : Mar '13
Dear Shareholders,
 
 At the very outset, I would thank you for being with us and reposing
 your confidence on the management. We make all possible efforts to meet
 the highest standards for our products. Our focus is quality and we
 believe in delivering nothing but the best.
 
 Herein, I am pleased to write to you about your Company''s performance
 for the financial year 2012-13. During Fiscal
 
 13, your Company posted revenue of Rs.11030.52 Mn.  and Profit after
 Tax of Rs.530.36 Mn. We have started the new fiscal with confidence and
 positivity. I do believe that the decisions by management over the last
 year will yield positive results in the coming year. We have made
 impressive strides towards the branded generic space and at the same
 time maintaining our momentum towards manufacturing operations and
 technology development.  The idea behind the above strategy is to make
 your Company''s presence felt across the pharmaceutical value chain
 and at the same time provide impetus to its growth. You will be glad to
 hear that we have made appreciable headway in nano- and biotechnology
 areas. FY 13 has been a very challenging year for all of us. The
 economic scenario is not cheerful and power cuts have posed problems.
 But please be assured that capital expenditure plan is on track and
 your Company''s infrastructure development is well on target. You will
 be delighted to know that your Company''s facilities in Vizag and
 Cuddalore will soon be ready to support the expansion of next growth
 phase.
 
 I am very happy to share with you that Shasun has the highest number of
 phase-3 molecules in the pipeline.  All this has the potential of being
 translated into far greater supplier opportunities for us in the near
 future. On the regulatory side, we have received approvals from key
 regulatory agencies for our API and Formulations divisions and have
 acquired accreditation from all majority agencies post their
 inspections.
 
 The performance of the CRAMS division has been encouraging. We have
 signed agreement for about 5 products with one of the top 3 generic
 players in the world. This augurs well for the business unit in FY14.
 
 EHS (Environment, Health and Safety) play an integral role in your
 Company''s functioning. We are committed to promoting the best EHS
 practices for wholesome and holistic development of your Company and
 its people.  Your Company has invested in reverse osmosis plants,
 multiple-effect evaporators, agitated thin film driers and an activated
 carbon bed facility for fugitive emissions. Apart from this, the
 environment around your Company''s factory is regularly monitored by
 MOEF-approved labs. The above expounds our commitment towards exemplary
 EHS practices. Various audits by customers and consultants have also
 established Shasun''s EHS practice as amongst the best in the industry
 in the whole of our country.
 
 We take our corporate social responsibility seriously and have taken
 humble efforts to contribute to the community we live in. We have
 partnered with Sankar Foundation Eye Hospital in Vizag, Andhra Pradesh,
 to roll out awareness programmes, health camps, and have funded
 surgeries for the poor. SPSL in the UK has been supporting
 apprenticeships through a new initiative and has partnered with the
 Northumberland County Council to make this a success. The waste water
 management programmes have also been refurbished and the initiative has
 succeeded in involving people from the community on an on-going basis.
 
 The future looks exciting and your Company is all geared for value
 creation. I am confident and enthused as we head towards our goal. I
 would like to place on record my sincere appreciation and thanks for
 the assistance and cooperation received from the Banks during the year
 under review. My deepest thanks to each of you for your continual
 support and confidence. Without you and the support of our customers,
 and suppliers, your Company would not have been where it is today.
 Finally I would like to end by thanking our staffs for their commitment
 and contribution towards achieving our business objectives.
 
 As I conclude a quote of Frank Lloyd Wright comes to my head, ''I know
 the price of success; dedication, hard work, and an unremitting
 devotion to the things you want to see happen.
 
 With warm regards,
 
 S. Abhaya Kumar
 
 Managing Director Chennai
Source : Dion Global Solutions Limited
Quick Links for shasunpharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.